story contributed by Genitope Corporation

UNMC to be site for non-Hodgkins lymphoma immunotherapy trial

FREMONT, Calif. — Genitope Corporation has initiated a phase 2 clinical trial evaluating the use of an immunotherapy method for some with follicular non-Hodgkin’s lymphoma (fNHL).

May 22, 2007

xOA n AnxnTfafI OGmhyUCs